Shu-ichi Ikeda
- Nephrology top 1%
- Molecular Biology top 2%
- Amyloidosis: Diagnosis, Treatment, Outcomes 23
- Ion channel regulation and function 6
- Physiology top 2%
- Alzheimer's disease research and treatments 10
- Sarcoidosis and Beryllium Toxicity Research 4
- Cell Biology top 2%
- Cellular transport and secretion 8
- Rheumatology top 5%
-
- Genetic Neurodegenerative Diseases 4
-
- Peripheral Neuropathies and Disorders 3
-
- Dermatological and Skeletal Disorders 3
- Co-authors
- Merrill D. BensonGiampaolo MerliniPer WestermarkMaria João SaraivaJoel N. BuxbaumJean D. SipeYukio AndoGen Sobue
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Shu-ichi Ikeda
42 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Nephrology 408
- Molecular Biology 2.6k
- Physiology 956
- Cell Biology 550
- Rheumatology 324
Countries citing papers authored by Shu-ichi Ikeda
This map shows the geographic impact of Shu-ichi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-ichi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-ichi Ikeda more than expected).
Fields of papers citing papers by Shu-ichi Ikeda
This network shows the impact of papers produced by Shu-ichi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-ichi Ikeda. The network helps show where Shu-ichi Ikeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu-ichi Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 26 | |
| 2 | Guideline of transthyretin-related hereditary amyloidosis for cliniciansbreakdown → | 2013 | 493 |
| 3 | 2013 | 107 | |
| 4 | 2012 | 212 | |
| 5 | 2012 | 10 | |
| 6 | 2011 | 57 | |
| 7 | 2010 | 16 | |
| 8 | 2010 | 243 | |
| 9 | 2009 | 28 | |
| 10 | 2007 | 4 | |
| 11 | 2005 | 248 | |
| 12 | 2005 | 29 | |
| 13 | 2004 | 36 | |
| 14 | 2001 | 9 | |
| 15 | 2001 | 12 | |
| 16 | 1999 | 142 | |
| 17 | 1999 | 70 | |
| 18 | 1999 | 2 | |
| 19 | 1999 | 5 | |
| 20 | 1999 | 42 |
About Shu-ichi Ikeda
Shu-ichi Ikeda is a scholar working on Cell Biology, Physiology and Neurology, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers), Alzheimer's disease research and treatments (10 papers), Cellular transport and secretion (8 papers), Ion channel regulation and function (6 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers), Genetic Neurodegenerative Diseases (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Dermatological and Skeletal Disorders (3 papers). The work is most often cited by research in Nephrology (408 citations), Molecular Biology (2.6k citations) and Physiology (956 citations). Shu-ichi Ikeda has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Merrill D. Benson, Giampaolo Merlini, Per Westermark, Maria João Saraiva, Joel N. Buxbaum, Jean D. Sipe, Yukio Ando, Gen Sobue, Blas Frangione and Colin L. Masters. Their work appears in journals such as Circulation, Brain and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.